Search research articles
Contact Us
Filters
Showing results (201-210 of 353) with videos related to
Page
of 36
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model
Kai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Thrombosis and Haemostasis
|
August 3, 2002
Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion
Kai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Journal of the American Heart Association
|
November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial
Anirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
American Heart Journal
|
September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Akshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JAMA Cardiology
|
March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study
Steven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
The American Journal of Medicine
|
July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial
Daniel H Solomon, M Elaine Husni, Peter A Libby, et al.
The Journal of Invasive Cardiology
|
June 30, 2015
Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial
Marco G Mennuni, George D Dangas, Roxana Mehran, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Endocrine Connections
|
March 9, 2026
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK
Thomas van Sloten, Steven H J Hageman, Jan Westerink, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials
Jennifer Yu, Roxana Mehran, Tim Clayton, et al.
Page
of 36
Search research articles
Search
Showing results (201-210 of 353) with videos related to
Sort By:
Page
of 36
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model
Kai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Thrombosis and Haemostasis
|
August 3, 2002
Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion
Kai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Journal of the American Heart Association
|
November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial
Anirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
American Heart Journal
|
September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Akshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JAMA Cardiology
|
March 12, 2018
ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study
Steven E Nissen, Sreekumar G Pillai, Stephen J Nicholls, et al.
The American Journal of Medicine
|
July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial
Daniel H Solomon, M Elaine Husni, Peter A Libby, et al.
The Journal of Invasive Cardiology
|
June 30, 2015
Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial
Marco G Mennuni, George D Dangas, Roxana Mehran, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Endocrine Connections
|
March 9, 2026
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK
Thomas van Sloten, Steven H J Hageman, Jan Westerink, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials
Jennifer Yu, Roxana Mehran, Tim Clayton, et al.
Page
of 36